Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
imidazopyridine |
| gptkbp:ATCCode |
gptkb:N05CF03
|
| gptkbp:CASNumber |
82626-30-2
|
| gptkbp:category |
benzodiazepine
withdrawn drug imidazopyridine derivative |
| gptkbp:developedBy |
gptkb:Synthelabo
|
| gptkbp:hasMolecularFormula |
C19H19ClN2O
|
| https://www.w3.org/2000/01/rdf-schema#label |
alpidem
|
| gptkbp:legalStatus |
withdrawn
|
| gptkbp:mechanismOfAction |
GABAA receptor modulator
|
| gptkbp:relatedTo |
gptkb:zolpidem
zolimidine |
| gptkbp:retired |
liver toxicity
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
liver failure
hepatotoxicity |
| gptkbp:usedFor |
benzodiazepine
|
| gptkbp:withdrawn |
gptkb:France
other countries |
| gptkbp:bfsParent |
gptkb:YFL-577
|
| gptkbp:bfsLayer |
7
|